| Name |
Daunoblastina 2 mg/ml prašak i otapalo za otopinu za injekciju |
| Marketing Authorisation Number |
HR-H-350055974 |
| Active Substance |
daunorubicinklorid |
| Composition |
jedna bočica sadrži 20 mg daunorubicinklorida
nakon rekonstitucije s 10 ml otapala jedna bočica sadrži 2 mg/ml daunorubicinklorida |
| Pharmaceutical Form |
prašak i otapalo za otopinu za injekciju |
| Manufacturer |
Latina Pharma S.p.A., Sermoneta, Italija |
| Marketing Authorisation Holder |
Pfizer Croatia d.o.o., Slavonska avenija 6, Zagreb, Hrvatska |
| Marketing Authorisation Date |
27.02.2019 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/17-02/499 |
| Registration Number |
381-12-01/70-19-07 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product subject to restricted medical prescription
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
L01DB02 |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
